Response to FDA statement on termination of a primate nicotine research study

The US Food and Drug Administration (FDA)  announced yesterday that it terminated a study investigating the effects of nicotine in monkeys.  This announcement, which was accompanied by the release of many records and documents related to the animals’ care, is troubling for many reasons.  Among them, it again raises questions about oversight and decision-making. Nicotine … Continue reading Response to FDA statement on termination of a primate nicotine research study

FDA response to Goodall letter found lacking

On September 25, 2017, Dr. Scott Gottlieb , Commissioner of the U.S. Food & Drug Administration (FDA) replied to a scathing letter from Dr. Jane Goodall, where Goodall denounced what she called the “cruel and unnecessary nicotine addiction experiments on monkeys”. We previously evaluated that letter from Goodall and now do the same with Commissioner Gottlieb’s letter. … Continue reading FDA response to Goodall letter found lacking

Jane Goodall and White Coat Waste are wrong about nicotine addiction research

This open letter is from scientists and leaders in the addiction research community.  If you'd like to join the signatories listed below, please do in comments at the bottom of this article. Please also share with others with an interest in research on addiction. Smoking – and nicotine addiction – are sometimes easy targets for … Continue reading Jane Goodall and White Coat Waste are wrong about nicotine addiction research

The Problem With Jane Goodall’s “Expert” Opinion

On September 7, 2017, Dr. Jane Goodall wrote a scathing letter to Dr. Scott Gottlieb, Commissioner of the U.S. Food & Drug Administration (FDA) denouncing what she called the “cruel and unnecessary nicotine addiction experiments on monkeys” occurring there. The letter, which relies on the repeated use of opinion versus fact-based arguments by Goodall, is … Continue reading The Problem With Jane Goodall’s “Expert” Opinion